Literature DB >> 6257830

A study of the cross-reacting antigens on the intact foot-and-mouth disease virus and its 12S Subunits with antisera against the structural proteins.

R H Meloen, J Briaire.   

Abstract

Cross-reactions between two strains of foot-and-mouth disease virus (FMDV) belonging to different serotypes (A and O) were studied with intact virus and virus subunits and antisera produced against the isolated structural proteins. Anti-VP1 type O serum showed cross-reactive neutralizing activity, in contrast to the sera raised against intact virus type O, whereas anti-VP1 type A serum only neutralized homologous virus. Anti-VP2, VP3 and VP4 did not show neutralizing activity. In the enzyme-linked immunosorbent assay and radio-immunoassay anti-VP1, -VP2, and -VP3 sera reacted with the 12S virus subunits of both serotypes. No activity was obtained against VP4. Competition experiments with virus subunits of virus type A and O show that anti-VP1 serum is the most type-specific. Anti-VP2 serum is completely cross-reactive, while anti-VP3 serum reacted in an intermediate way. The identical reactions obtained with anti-VP2 sera and the homologous and heterologous virus subunits suggest that the exposed VP2 antigens are identical.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6257830     DOI: 10.1099/0022-1317-51-1-107

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  18 in total

1.  Capsid intermediates assembled in a foot-and-mouth disease virus genome RNA-programmed cell-free translation system and in infected cells.

Authors:  M J Grubman; D O Morgan; J Kendall; B Baxt
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

2.  Characterization of B-cell epitopes on IpaB, an invasion-associated antigen of Shigella flexneri: identification of an immunodominant domain recognized during natural infection.

Authors:  S Barzu; F Nato; S Rouyre; J C Mazie; P Sansonetti; A Phalipon
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

3.  Small peptides induce antibodies with a sequence and structural requirement for binding antigen comparable to antibodies raised against the native protein.

Authors:  H M Geysen; S J Barteling; R H Meloen
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

4.  Evidence for more than one important, neutralizing site on foot-and-mouth disease virus. Brief report.

Authors:  A A Thomas; R J Woortmeijer; S J Barteling; R H Meloen
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

5.  Antigenic sites on foot-and-mouth disease virus type A10.

Authors:  A A Thomas; R J Woortmeijer; W Puijk; S J Barteling
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

6.  An enzyme-linked immunosorbent assay (ELISA) for the primary diagnosis of foot-and-mouth disease. Characterization and comparison with complement fixation.

Authors:  P Have; J C Lei; K Schjerning-Thiesen
Journal:  Acta Vet Scand       Date:  1984       Impact factor: 1.695

7.  Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid.

Authors:  H M Geysen; R H Meloen; S J Barteling
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

8.  Comparison of the major antigenic determinants of different serotypes of foot-and-mouth disease virus.

Authors:  A Cheung; J DeLamarter; S Weiss; H Küpper
Journal:  J Virol       Date:  1983-11       Impact factor: 5.103

9.  A liquid phase affinity capture assay using magnetic beads to study protein-protein interaction: the poliovirus-nanobody example.

Authors:  Lise Schotte; Bart Rombaut; Bert Thys
Journal:  J Vis Exp       Date:  2012-05-29       Impact factor: 1.355

10.  Identification and characterization of B-cell epitopes of IpaC, an invasion-associated protein of Shigella flexneri.

Authors:  A Phalipon; J Arondel; F Nato; S Rouyre; J C Mazie; P J Sansonetti
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.